Ask Michael Burke Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Merritt who wrote (42638)	1/8/1999 5:18:00 PM
From: Ilaine	Read Replies (2) of 132070

Hi Merritt, I took a closer look at Celgene and Entremed, they announced yesterday that Celgene would take over Entremed's ongoing clinical trials using thalidomide. I then looked at the NIH site on ongoing clinical trials and was surprised to learn that Entremed had testing thalidomide as an anti-angiogenesis drug. It really is weird to think of thalidomide as the new wonder drug, the birth defects it causes are so horrific, but I would expect an oncology drug to cause horrible birth defects, so maybe it isn't so strange, after all.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next